WuXi PharmaTech Recertified ISO 9001:2000
Dec 22, 2006
December 22, 2006 – Shanghai, China – WuXi PharmaTech's 250,000 sq. ft. JinShan GMP manufacturing wholly owned subsidiary, SynTheAll Pharmaceuticals, announced today that it has been recertified International Organization for Standardization (ISO) 9001:2000 compliant by SGS, a third-party auditing firm.
Established in 2004 as the manufacturing unit of WuXi PharmaTech, China's leading supplier of pharmaceutical R&D outsourcing services, SynTheAll Pharmaceuticals was initially ISO 9001:2000 certified last year. SynTheAll provides GMP manufacturing services including process research, scale-up production, and Active Pharmaceutical Intermediates (API) and advanced intermediates manufacturing.
"Receiving ISO 9001:2000 recertification is testament to our unwavering commitment to quality, process consistency, and continuous improvement. At WuXi PharmaTech, we are continuously raising the bar for our quality expectations and standards. It is wonderful to be again recognized by ISO, however our most difficult standard to meet, is our own," commented Dr. Ge Li, Chairman and CEO of WuXi PharmaTech.
SGS is the world's leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 46,000 employees, SGS operates a network of over 1,000 offices and laboratories around the world.
ISO is a network of the national standards institutes of 156 countries. ISO standards specify the requirements for state-of-the-art products, services, processes, materials and systems, and for good conformity assessment, managerial and organizational practice. ISO 9001:2000 is based on eight quality management principles: customer focus, leadership, involvement of people, process approach, system approach, continual improvement, fact based decision making, and mutually beneficial supplier relationships.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.